Test Code PNEFS Neuroimmunology Antibody Follow-up, Serum
Reporting Name
Neuroimmunology Ab Follow-up, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Monitoring patients who have previously tested positive for one or more antibodies within the past 5 years in a Mayo Neuroimmunology Laboratory serum evaluation
Method Name
AGN1S, AMPHS, ANN1S, ANN2S, ANN3S, CRMS, DPPIS, GL1IS, PCAB2, PCABP, PCATR, GRFIS, IG5IS, ITPIS, GFAIS, SRPIS, NIFIS, APBIS, NCDIS, SP5IS, SP7IS, PDEIS, T46IS: Indirect Immunofluorescence Assay (IFA)
AMPCS, CS2CS, DPPCS, GABCS, GL1CS, LG1CS, NMDCS, GRFCS, IG5CS, ITPCS, GFACS, NFLCS, NFHCS, AINCS, APBCS, NCDCS, SP5CS, SP7CS, T46CS: Cell Binding Assay (CBA)
CCPQ, GANG: Radioimmunoassay (RIA)
ACMFS: Flow Cytometry (FACS)
IGG_A, IGG_D, IGM_A, IGM_D, IGM_M: Enzyme-linked Immunosorbent Assay (EIA)
AGNBS, AMIBS, AN1BS, AN2BS, PC1BS, PCTBS, SRPBS: Immunoblot (IB)
Ordering Guidance
This test is only appropriate for follow-up in patients who have previously tested positive in a serum test. If patients have not previously been positive in a serum test, order one of the following:
-AIAES / Axonal Neuropathy, Autoimmune/Paraneoplastic Evaluation, Serum
-CDS1 / CNS Demyelinating Disease Evaluation, Serum
-CIDP / Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Eval, Serum
-DYS2 / Dysautonomia, Autoimmune/Paraneoplastic Evaluation, Serum
-DMS2 / Dementia, Autoimmune/Paraneoplastic Evaluation, Serum
-ENS2 / Encephalopathy, Autoimmune/Paraneoplastic Evaluation, Serum
-EPS2 / Epilepsy, Autoimmune/Paraneoplastic Evaluation, Serum
-GID2 / Gastrointestinal Dysmotility, Autoimmune/Paraneoplastic Evaluation, Serum
-MAS1 / Myelopathy, Autoimmune/Paraneoplastic Evaluation, Serum
-MDS2 / Movement Disorder, Autoimmune/Paraneoplastic Evaluation, Serum
-MGLE / Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, Serum
-MGMR / Myasthenia Gravis Evaluation with Muscle-Specific Kinase (MuSK) Reflex, Serum
-NMS1 / Necrotizing Myopathy Evaluation, Serum
-PCDES / Pediatric Autoimmune Encephalopathy/CNS Disorder Evaluation, Serum
-SPPS / Stiff-Person Spectrum Disorders/PERM Evaluation, Serum
This test should not be requested in patients who have recently received radioisotopes, therapeutically or diagnostically, because of potential assay interference. The specific waiting period before specimen collection will depend on the isotope administered, the dose given, and the clearance rate in the individual patient. Specimens will be screened for radioactivity prior to analysis. Radioactive specimens received in the laboratory will be held 1 week and assayed if sufficiently decayed or canceled if radioactivity remains.
Specimen Required
Collection Container/Tube:
Preferred:Red top
Acceptable:Serum gel
Submission Container/Tube: 13 x 75-mm plastic screw-top vial
Specimen Volume: 4 mL
Collection Instructions: Centrifuge within 2 hours. Aliquot and ship in 13 x 75-mm plastic screw-top vial.
Specimen Type
SerumSpecimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Reference Values
Test ID |
Reporting Name |
Methodology* |
Reference Value |
GANG |
AChR Ganglionic Neuronal Ab, S |
RIA |
≤0.02 nmol/L |
ACMFS |
AChR Modulating Flow Cytometry, S |
FACS |
Negative |
AGNBS |
AGNA-1 Immunoblot, S |
IB |
Negative |
AINCS |
Alpha Internexin CBA, S |
CBA |
Negative |
AMPCS |
AMPA-R Ab CBA, S |
CBA |
Negative |
AMPHS |
Amphiphysin Ab, S |
IFA |
Negative |
AMIBS |
Amphiphysin Immunoblot, S |
IB |
Negative |
AN1BS |
ANNA-1 Immunoblot, S |
IB |
Negative |
AN2BS |
ANNA-2 Immunoblot, S |
IB |
Negative |
AGN1S |
Anti-Glial Nuclear Ab, Type 1 |
IFA |
Negative |
ANN1S |
Anti-Neuronal Nuclear Ab, Type 1 |
IFA |
Negative |
ANN2S |
Anti-Neuronal Nuclear Ab, Type 2 |
IFA |
Negative |
ANN3S |
Anti-Neuronal Nuclear Ab, Type 3 |
IFA |
Negative |
APBCS |
AP3B2 CBA, S |
CBA |
Negative |
APBIS |
AP3B2 IFA, S |
IFA |
Negative |
CS2CS |
CASPR2-IgG CBA, S |
CBA |
Negative |
CRMS |
CRMP-5-IgG, S |
IFA |
Negative |
DPPCS |
DPPX Ab CBA, S |
CBA |
Negative |
DPPIS |
DPPX Ab IFA, S |
IFA |
Negative |
GABCS |
GABA-B-R Ab CBA, S |
CBA |
Negative |
GFACS |
GFAP CBA, S |
CBA |
Negative |
GFAIS |
GFAP IFA, S |
IFA |
Negative |
GRFCS |
GRAF1 CBA, S |
CBA |
Negative |
GRFIS |
GRAF1 IFA, S |
IFA |
Negative |
IGG_A |
IgG Asialo. GM1 |
EIA |
Negative |
IGG_D |
IgG Disialo. GD1b |
EIA |
Negative |
IG5CS |
IgLON5 CBA, S |
CBA |
Negative |
IG5IS |
IgLON5 IFA, S |
IFA |
Negative |
IGM_A |
IgM Asialo. GM1 |
EIA |
Negative |
IGM_D |
IgM Disialo. GD1b |
EIA |
Negative |
IGM_M |
IgM Monos. GM1 |
EIA |
Negative |
ITPCS |
ITPR1 CBA, S |
CBA |
Negative |
ITPIS |
ITPR1 IFA, S |
IFA |
Negative |
LG1CS |
LGI1-IgG CBA, S |
CBA |
Negative |
GL1CS |
mGluR1 Ab CBA, S |
CBA |
Negative |
GL1IS |
mGluR1 Ab IFA, S |
IFA |
Negative |
NCDCS |
Neurochondrin CBA, S |
CBA |
Negative |
NCDIS |
Neurochondrin IFA, S |
IFA |
Negative |
NFHCS |
NIF Heavy Chain CBA, S |
CBA |
Negative |
NIFIS |
NIF IFA, S |
IFA |
Negative |
NFLCS |
NIF Light Chain CBA, S |
CBA |
Negative |
NMDCS |
NMDA-R Ab CBA, S |
CBA |
Negative |
CCPQ |
P/Q-Type Calcium Channel Ab |
RIA |
≤0.02 nmol/L |
PC1BS |
PCA-1 Immunoblot, S |
IB |
Negative |
PCTBS |
PCA-Tr Immunoblot, S |
IB |
Negative |
PCABP |
Purkinje Cell Cytoplasmic Ab Type 1 |
IFA |
Negative |
PCAB2 |
Purkinje Cell Cytoplasmic Ab Type 2 |
IFA |
Negative |
PCATR |
Purkinje Cell Cytoplasmic Ab Type Tr |
IFA |
Negative |
SP5CS |
Septin-5 CBA, S |
CBA |
Negative |
SP5IS |
Septin-5 IFA, S |
IFA |
Negative |
SP7CS |
Septin-7 CBA, S |
CBA |
Negative |
SP7IS |
Septin-7 IFA, S |
IFA |
Negative |
SRPIS |
SRP IFA Screen, S |
IFA |
Negative |
SRPBS |
SRP Immunoblot, S |
IB |
Negative |
PDEIS |
PDE10A Ab IFA, S |
IFA |
Negative |
T46CS |
TRIM46 Ab CBA, S |
CBA |
Negative |
T46IS |
TRIM46 Ab IFA, S |
IFA |
Negative |
*Methodology abbreviations:
CBA: Cell-binding assay
FACS: Flow Cytometry
IB: Immunoblot
IFA: Immunofluorescence assay
RIA: Radioimmunoassay
WB: Western blot (WB)
Interpretation
Antibodies directed at onconeural proteins shared by neurons, muscle, and certain cancers are valuable serological markers of a patient's immune response to cancer. They are not found in healthy subjects and are usually accompanied by subacute neurological signs and symptoms. Several autoantibodies have a syndromic association, but no known autoantibody predicts a specific neurological syndrome. Conversely, a positive autoantibody profile has 80% to 90% predictive value for a specific cancer. It is not uncommon for more than one paraneoplastic autoantibody to be detected, each predictive of the same cancer.
Day(s) Performed
Varies
Report Available
VariesTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
83519 GANG (if appropriate)
86043 ACMFS (if appropriate)
84182 AGNBS (if appropriate)
86255 AINCS (if appropriate)
86255 AMPCS (if appropriate)
86255 AMPHS (if appropriate)
84182 AMIBS (if appropriate)
84182 AN1BS (if appropriate)
84182 AN2BS (if appropriate)
86255 AGN1S (if appropriate)
86255 ANN1S (if appropriate)
86255 ANN2S (if appropriate)
86255 ANN3S (if appropriate)
86255 APBCS (if appropriate)
86255 APBIS (if appropriate)
86255 CS2CS (if appropriate)
86255 CRMS (if appropriate)
86255 DPPCS (if appropriate)
86255 DPPIS (if appropriate)
86255 GABCS (if appropriate)
86255 GFACS (if appropriate)
86255 GFAIS (if appropriate)
86255 GRFCS (if appropriate)
86255 GRFIS (if appropriate)
83516 IGG_A (if appropriate)
83516 IGG_D (if appropriate)
86255 IG5CS (if appropriate)
86255 IG5IS (if appropriate)
83516 IGM_A (if appropriate)
83516 IGM_D (if appropriate)
83516 IGM_M (if appropriate)
86255 ITPCS (if appropriate)
86255 ITPIS (if appropriate)
86255 LG1CS (if appropriate)
86255 GL1CS (if appropriate)
86255 GL1IS (if appropriate)
86255 NCDCS (if appropriate)
86255 NCDIS (if appropriate)
86255 NFHCS (if appropriate)
86255 NIFIS (if appropriate)
86255 NFLCS (if appropriate)
86255 NMDCS (if appropriate)
83519 CCPQ (if appropriate)
84182 PC1BS (if appropriate)
84182 PCTBS (if appropriate)
86255 PCABP (if appropriate)
86255 PCAB2 (if appropriate)
86255 PCATR (if appropriate)
86255 PDEIS (if appropriate)
86255 SP5CS (if appropriate)
86255 SP5IS (if appropriate)
86255 SP7CS (if appropriate)
86255 SP7IS (if appropriate)
86255 SRPIS (if appropriate)
84182 SRPBS (if appropriate)
86255 T46CS (if appropriate)
86255 T46IS (if appropriate)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
PNEFS | Neuroimmunology Ab Follow-up, S | 80615-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
84300 | Neuroimmunology Ab Follow-up, S | 80615-8 |
Forms
If not ordering electronically, complete, print, and send a Neurology Specialty Testing Client Test Request (T732) with the specimen.
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
GANG | AChR Ganglionic Neuronal Ab, S | No | No |
ACMFS | AChR Modulating Flow Cytometry, S | No | No |
AGNBS | AGNA-1 Immunoblot, S | No | No |
AINCS | Alpha Internexin CBA, S | No | No |
AMPCS | AMPA-R Ab CBA, S | No | No |
AMIBS | Amphiphysin Immunoblot, S | No | No |
AN1BS | ANNA-1 Immunoblot, S | No | No |
AN2BS | ANNA-2 Immunoblot, S | No | No |
AGN1S | Anti-Glial Nuclear Ab, Type 1 | No | No |
ANN1S | Anti-Neuronal Nuclear Ab, Type 1 | No | No |
ANN2S | Anti-Neuronal Nuclear Ab, Type 2 | No | No |
ANN3S | Anti-Neuronal Nuclear Ab, Type 3 | No | No |
CS2CS | CASPR2-IgG CBA, S | No | No |
CRMS | CRMP-5-IgG, S | No | No |
DPPCS | DPPX Ab CBA, S | No | No |
DPPIS | DPPX Ab IFA, S | No | No |
GABCS | GABA-B-R Ab CBA, S | No | No |
GFACS | GFAP CBA, S | No | No |
GFAIS | GFAP IFA, S | No | No |
GRFCS | GRAF1 CBA, S | No | No |
GRFIS | GRAF1 IFA, S | No | No |
IGG_A | IgG Asialo. GM1 | No | No |
IGG_D | IgG Disialo. GD1b | No | No |
IG5CS | IgLON5 CBA, S | No | No |
IG5IS | IgLON5 IFA, S | No | No |
IGM_A | IgM Asialo. GM1 | No | No |
IGM_D | IgM Disialo. GD1b | No | No |
IGM_M | IgM Monos. GM1 | No | No |
ITPCS | ITPR1 CBA, S | No | No |
ITPIS | ITPR1 IFA, S | No | No |
LG1CS | LGI1-IgG CBA, S | No | No |
GL1CS | mGluR1 Ab CBA, S | No | No |
GL1IS | mGluR1 Ab IFA, S | No | No |
NIFIS | NIF IFA, S | No | No |
NFLCS | NIF Light Chain CBA, S | No | No |
NMDCS | NMDA-R Ab CBA, S | No | No |
CCPQ | P/Q-Type Calcium Channel Ab | No | No |
PC1BS | PCA-1 Immunoblot, S | No | No |
PCTBS | PCA-Tr Immunoblot, S | No | No |
PCABP | Purkinje Cell Cytoplasmic Ab Type 1 | No | No |
PCAB2 | Purkinje Cell Cytoplasmic Ab Type 2 | No | No |
PCATR | Purkinje Cell Cytoplasmic Ab Type Tr | No | No |
SRPIS | SRP IFA Screen, S | No | No |
SRPBS | SRP Immunoblot, S | No | No |
AMPHS | Amphiphysin Ab, S | No | No |
APBCS | AP3B2 CBA, S | No | No |
APBIS | AP3B2 IFA, S | No | No |
NCDCS | Neurochondrin CBA, S | No | No |
NCDIS | Neurochondrin IFA, S | No | No |
NFHCS | NIF Heavy Chain CBA, S | No | No |
SP5CS | Septin-5 CBA, S | No | No |
SP5IS | Septin-5 IFA, S | No | No |
SP7CS | Septin-7 CBA, S | No | No |
SP7IS | Septin-7 IFA, S | No | No |
PDEIS | PDE10A Ab IFA, S | No | No |
T46CS | TRIM46 Ab CBA, S | No | No |
T46IS | TRIM46 Ab IFA, S | No | No |